Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Major clinical study demonstrates efficacy and safety of Aviron's intranasal flu vaccine

July 14, 1999

HMR grants Fujisawa option to license malononitrilamide compounds

July 14, 1999

Phase I trials evaluating J695 now under way

July 13, 1999

Celgene reports potent, specific immune responses for thalidomide analogues

July 13, 1999

Rapamune up for FDA advisory committee review in late July

July 12, 1999

Anti-CD154 antibody facilitates islet allograft survival in highly relevant preclinical model

July 12, 1999

P2X7 receptor antagonists described in recent patent literature

July 12, 1999

Human Genome Sciences discovery may lead to novel immunotherapies and vaccines

July 12, 1999

Vaxin develops technology for transdermal vaccine delivery

July 9, 1999

Combination vaccine more effective against Lyme disease

July 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....